Prediction of Resistance to (177)Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers. Sartor O, Ledet E, Huang M, Schwartz J, et al. J Nucl Med 2023;64:1721-1725.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sartor O, Ledet E, Huang M, Schwartz J, et al. Prediction of Resistance to (177)Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers. J Nucl Med 2023;64:1721-1725.
PMID: 37770113